the significance of tucatinib trastuzumab as a chemotherapy-free option for her2 metastatic btc
Published 1 year ago • 173 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
2:21
sgntuc-019: tucatinib trastuzumab for previously treated her2 metastatic biliary tract cancer
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
1:24
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
0:55
her2climb-05: tucatinib with trastuzumab and pertuzumab as maintenance therapy for her2 mbc
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:46
choosing between tucatinib and t-dxd in her2 breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
1:29
poziotinib for her2-positive metastatic breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer